HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SB 204990

Also Known As:

+-(3R*,5S*)-3-carboxy-11-(2,4-dichlorophenyl)-3,5-dihydroxyundecanoic acid

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Lactones: 1549
  - SB 204990: 1

Experts

1.	Feng, Xiaojun: 1 article (01/2020)
2.	Shen, Ai-Zong: 1 article (01/2020)
3.	Xu, Suowen: 1 article (01/2020)
4.	Zhang, Lei: 1 article (01/2020)

Related Diseases

1.	Atherosclerosis 01/01/2020 - "Hereby, we provide a updated review of the expression, regulation, genetics, functions of ACLY in lipid metabolism and atherosclerosis, and highlight the therapeutic potential of ACLY inhibitors (such as bempedoic acid, SB-204990, and other naturally-occuring inhibitors) to treat atherosclerotic cardiovascular diseases. "
2.	Cardiovascular Diseases (Cardiovascular Disease) 01/01/2020 - "Hereby, we provide a updated review of the expression, regulation, genetics, functions of ACLY in lipid metabolism and atherosclerosis, and highlight the therapeutic potential of ACLY inhibitors (such as bempedoic acid, SB-204990, and other naturally-occuring inhibitors) to treat atherosclerotic cardiovascular diseases. "

Related Drugs and Biologics

1.	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acid